Predicting stroke in patients without atrial fibrillation.
CHA2DS2-VASc
coronary angiography
coronary artery disease
prevention
stroke
thromboembolism
Journal
European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
revised:
06
02
2019
received:
14
10
2018
accepted:
13
03
2019
pubmed:
19
3
2019
medline:
19
3
2019
entrez:
19
3
2019
Statut:
ppublish
Résumé
Only few studies in selected cohorts have examined whether the CHA Patients with coronary angiography performed between 2004 and 2012 were grouped according to CHA In total, 78 233 patients were included with group sizes varying between 8299 (CHA Among patients undergoing coronary angiography, the CHA
Sections du résumé
BACKGROUND
BACKGROUND
Only few studies in selected cohorts have examined whether the CHA
MATERIALS AND METHODS
METHODS
Patients with coronary angiography performed between 2004 and 2012 were grouped according to CHA
RESULTS
RESULTS
In total, 78 233 patients were included with group sizes varying between 8299 (CHA
CONCLUSIONS
CONCLUSIONS
Among patients undergoing coronary angiography, the CHA
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13103Subventions
Organisme : Aarhus University Hospital
Informations de copyright
© 2019 Stichting European Society for Clinical Investigation Journal Foundation.
Références
Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: A statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2014;45(12):3754-3832.
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962.
January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2014;64(21):e1-e76.
Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124.
Lip G, Nielsen PB. Should patients with atrial fibrillation and 1 stroke risk factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) be anticoagulated? Yes: even 1 stroke risk factor confers a real risk of stroke. Circulation. 2016;133(15):1498-1503; discussion 1503.
Nielsen PB, Larsen TB, Skjøth F, Overvad TF, Lip G. Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study. Sci Rep. 2016;6:27410.
Lip G, Nieuwlaat R, Pisters R, Lane DA, Crijns H. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263-272.
Lip G, Skjøth F, Nielsen PB, Kjaeldgaard JN, Larsen TB. Effectiveness and safety of standard-dose nonvitamin K antagonist oral anticoagulants and warfarin among patients with atrial fibrillation with a single stroke risk factor: a nationwide cohort study. JAMA Cardiol. 2017;2(8):872-881.
Lip G, Freedman B, De Caterina R, Potpara TS. Stroke prevention in atrial fibrillation: past, present and future. Thromb Haemost. 2017;117(7):1230-1239.
Christiansen CB, Gerds TA, Olesen JB, et al. Atrial fibrillation and risk of stroke: a nationwide cohort study. Europace. 2016;18(11):1689-1697.
Schmidt M, Maeng M, Madsen M, Sørensen HT, Jensen LO, Jakobsen C-J. The Western Denmark heart registry: its influence on cardiovascular patient care. J Am Coll Cardiol. 2018;71(11):1259-1272.
Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The danish national hospital register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268.
Frank L. When an entire country is a cohort. Science. 2000;287(5462):2398-2399.
Johannesdottir SA, Horvath-Puho E, Ehrenstein V, Schmidt M, Pedersen L, Sorensen HT. Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions. Clin Epidemiol. 2012;4:303-313.
Schmidt M, Schmidt S, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449.
Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541-549.
Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706.
Lip G, Lin H-J, Chien K-L, et al. Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study. Int J Cardiol. 2013;168(1):414-419.
Welles CC, Whooley MA, Na B, Ganz P, Schiller NB, Turakhia MP. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study. Am Hear J. 2011;162(3):555-561.
Mitchell LB, Southern DA, Galbraith D, Ghali WA, Knudtson M, Wilton SB. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores. Heart. 2014;100(19):1524-1530.
Kashani RG, Sareh S, Genovese B, et al. Predicting postoperative atrial fibrillation using CHA2DS2-VASc scores. J Surg Res. 2015;198(2):267-272.
Lau K-K, Chan P-H, Yiu K-H, et al. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke. Cardiol J. 2014;21(5):474-483.
Eckman MH, Singer DE, Rosand J, Greenberg SM. Moving the tipping point the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2011;4(1):14-21.
Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017;377(14):1319-1330.
Kittelson JM, Steg PG, Halperin JL, et al. Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation. Thromb Haemost. 2016;116(3):544-553.
Marfella R, Sasso FC, Siniscalchi M, et al. Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. J Am Coll Cardiol. 2013;62(6):525-530.
Healey JS, Alings M, Ha A, et al. Subclinical atrial fibrillation in older patients. Circulation. 2017;136(14):1276-1283.
Sanna T, Diener H-C, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478-2486.
Gladstone DJ, Spring M, Dorian P, et al. Atrial Fibrillation in Patients with Cryptogenic Stroke. N Engl J Med. 2014;370(26):2467-2477.
Israel C, Kitsiou A, Kalyani M, et al. Detection of atrial fibrillation in patients with embolic stroke of undetermined source by prolonged monitoring with implantable loop recorders. Thromb Haemost. 2017;117(10):1962-1969.